| Name | Title | Contact Details |
|---|
Creative Solutions International is a Arlington, VA-based company in the Computers and Electronics sector.
CyberMDX is a leading provider of medical cyber security, delivering zero touch visibility and threat prevention for medical devices and clinical assets.
GoLogiq Inc. is a US-based global provider of fintech and mobile solutions for digital transformation and consumer data analytics. Its software platforms are comprised of CreateApp, a mobile app development and publishing platform for small-to-medium sized businesses; AtozGo™, a hyper-local app-based delivery platform; AtozPay™, an eWallet for mobile top-up, e-commerce purchases, bill payment and microfinance; and Radix™, a Big Data analytics platform. Through the company`s subsidiary, GenFi Financial Group, Inc. and its subsidiaries (GENFI Group), which is a part of its recent acquisition of GammaRey, Inc., GoLogiq provides wealth management, direct-to-consumer lending platforms, mortgage broking, accounting, taxation advice, reporting, structuring, and solutions for individual investors and small-to-medium businesses in Australia. Through the GENFI Group, the company also offers compliance services under its Australian Financial Services License including advice regarding Managed Investment Schemes (MIS), Self-Managed Superannuation Funds (SMSF) and other ancillary services.
DefinedLogic, a business and technology consultancy that offers its clients with mobile and web-based solutions to develop their businesses.
Cota is a technology platform that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the care of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.